Integrative health check reveals suboptimal levels in a number of vital biomarkers

Advances in Integrative Medicine

Volumn 2, Issue 3, 2015, Pages 135-140

  Travica, Nikolaj ^a   Ried, Karin ^a   Bujnowski, Robert ^a   Sali, Avni ^a  

^a National Institute of Integrative Medicine   (Australia)

Author keywords

Biomarkers; Health check; Homocysteine; Iodine; Vitamin B12; Vitamin D

Indexed keywords

CYANOCOBALAMIN; FERRITIN; GLUCOSE; HEMOGLOBIN; HOMOCYSTEINE; IODINE; MINERAL; TRANSFERRIN; VITAMIN D;

ADULT; AGE; AGED; ARTICLE; BLOOD CELL COUNT; BODY MASS; DEMENTIA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENDER; HEALTH STATUS; HUMAN; HYPERTENSION; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; MALE; MIDDLE AGED; NEOPLASM; PRIORITY JOURNAL; SCREENING; SEASONAL VARIATION; THYROID DISEASE; THYROID FUNCTION TEST;

EID: 84982690257     PISSN: 22129588     EISSN: 22129596     Source Type: Journal    
DOI: 10.1016/j.aimed.2015.11.002     Document Type: Article

References (49)

1. Chronic Diseases Are Leading Causes of Death and Disability in Australia 2012, The Department of Health, Available at: http://www.health.gov.au/internet/main/publishing.nsf/content/chronic-disease.
2. National Health Survey: Summary of Results, 2007-08 2008, Australian Bureau of Statistics, Available at: http://www.abs.gov.au/ausstats/abs.nsf/mf/4364.0.
3. Australia's Health 2012 2012, Australian Institute of Health and Welfare (AIHW), Available at: http://www.aihw.gov.au/publication-detail/?id=10737422172.
4. Morabia A., Zhang F. History of medical screening: from concepts to action. Postgrad. Med. J. 2004, 80(946):463-469.
5. World Health Organization Definition of Health 1960, World Health Organization, Available at: http://www.who.int/about/definition/en/print.html.
6. Britt H., Henderson M.G., Bayram J., Harrison C., Valenti C., Wong L., Gordon C., Pollack J., Pan A.J., Charles Y.J. General Practice Activity in Australia 2013-14, Sydney 2014.
7. Joshi D., Center J.R., Eisman J.A. Vitamin D deficiency in adults. Aust. Prescrib. 2010, 33(4):103-106.
8. Płudowski P., Kryśkiewicz E., Karczmarewicz E. Vitamin D provision and supplementation standards. Postepy Nauk Medycznych 2012.
9. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357(3):266-281.
10. Mitsuyama Y., Kogoh H. Serum and cerebrospinal fluid vitamin B12 levels in demented patients with CH3-B12 treatment: preliminary study. Psychiatry Clin. Neurosci. 1988, 42(1):65-71.
11. Iso H., Moriyama Y., Sato S., Kitamura A., Tanigawa T., Yamagishi K., et al. Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese. Circulation 2004, 109(22):2766-2772.
12. NIIM Integrative Health Check, National Institute of Integrative Medicine, Melbourne, Australia.
13. Diamond T.H., Eisman J.A., Mason R.S., Nowson C.A., Pasco J.A., Sambrook P.N., et al. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med. J. Aust. 2005, 182(6):281-285.
14. Webb A.R., Engelsen O. Calculated ultraviolet exposure levels for a healthy vitamin D status. Photochem. Photobiol. 2006, 82(6):1697-1703.
15. Rhodes L.E., Webb A.R., Fraser H.I., Kift R., Durkin M.T., Allan D., et al. Recommended summer sunlight exposure levels can produce sufficient but not the proposed optimal 25 (OH) D levels at UK latitudes. J. Invest. Dermatol. 2010, 130(5):1411-1418.
16. Fuller K.E., Casparian J.M. Vitamin D: balancing cutaneous and systemic considerations. South. Med. J. 2001, 94(1):58-64.
17. Del Valle H.B., Yaktine A.L., Taylor C.L., Ross A.C. Dietary Reference Intakes for Calcium and Vitamin D 2011, National Academies Press.
18. Holick M.F. Environmental factors that influence the cutaneous production of vitamin D. Am. J. Clin. Nutr. 1995, 61(3):638S-645S.
19. Garnefski N., Teerds J., Kraaij V., Legerstee J., van den Kommer T. Cognitive emotion regulation strategies and depressive symptoms: differences between males and females. Pers. Individ. Dif. 2004, 36(2):267-276.
20. Bruce D.G., St.John A., Nicklason F., Goldswain P. Secondary hyperparathyroidism in patients from Western Australia with hip fracture: relationship to type of hip fracture, renal function, and vitamin D deficiency. J. Am. Geriatr. Soc. 1999, 47(3):354-359.
21. Flicker L., Mead K., MacInnis R.J., Nowson C., Scherer S., Stein M.S., et al. Serum vitamin D and falls in older women in residential care in Australia. J. Am. Geriatr. Soc. 2003, 51(11):1533-1538.
22. Holick M.F. Vitamin D and bone health. J. Nutr. 1996, 126(4 Suppl.):1159S-1164S.
23. Holick M.F. Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr. Opin. Endocrinol. Diabetes Obes. 2002, 9(1):87-98.
24. Sanders K.M., Nowson C.A., Kotowicz M.A., Briffa K., Devine A., Reid I.R. Calcium and bone health: position statement for the Australian and New Zealand Bone and Mineral Society, Osteoporosis Australia and the Endocrine Society of Australia. Med. J. Aust. 2009, 190(6):316-320.
25. Benson J., Skull S. Hiding from the sun-vitamin D deficiency in refugees. Aust. Fam. Physician 2007, 36(5):355-357.
26. Brock K., Wilkinson M., Cook R., Lee S., Bermingham M. Associations with vitamin D deficiency in "at risk" Australians. J. Steroid Biochem. Mol. Biol. 2004, 89:581-588.
27. Ervin R.B., Wang C.-Y., Wright J.D., Kennedy-Stephenson J. Dietary intake of selected minerals for the United States population: 1999-2000. Energy 2004, 1(5):6.
28. World Health Organization Assessment of Iodine Deficiency Disorders and Monitoring Their Elimination: A Guide for Programme Managers 2007.
29. Delange F., Benoist Bd., Bürgi H. Determining median urinary iodine concentration that indicates adequate iodine intake at population level. Bull. World Health Organ. 2002, 80(8):633-636.
30. Trumbo P., Yates A.A., Schlicker S., Poos M. Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J. Am. Diet. Assoc. 2001, 101(3):294-301.
31. Pennington J., Schoen S. Total diet study: estimated dietary intakes of nutritional elements, 1982-1991. Int. J. Vitamin Nutr. Res. 1995, 66(4):350-362.
32. Als C., Keller A., Minder C., Haldimann M., Gerber H. Age- and gender-dependent urinary iodine concentrations in an area-covering population sample from the Bernese region in Switzerland. Eur. J. Endocrinol. 2000, 143(5):629-637.
33. Australian Health Survey: Biomedical Results for Nutrients, 2011-12 2013, Australian Bureau of Statistics, Available at: http://www.abs.gov.au/AUSSTATS/abs.nsf/DetailsPage/4364.0.55.0062011-12?OpenDocument.
34. Karatela R., Sainani G. Plasma homocysteine in obese, overweight and normal weight hypertensives and normotensives. Indian Heart J. 2008, 61(2):156-159.
35. Baltaci D., Kutlucan A., Öztürk S., Karabulut I., Yildirim H.A., Celer A., et al. Evaluation of vitamin B-12 level in middle-aged obese women with metabolic and non-metabolic syndrome: case-control study. Turk. J. Med. Sci. 2012, 42(5):802-809.
36. Van Tiggelen C., Peperkamp J., Tertoolen H. Assessment of vitamin B12 status in CSF. Am. J. Psychiatry 1984, 141(1):136-137.
37. Smith A.D., Smith S.M., De Jager C.A., Whitbread P., Johnston C., Agacinski G., et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS ONE 2010, 5(9):e12244.
38. Dommisse J. Subtle vitamin-B12 deficiency and psychiatry: a largely unnoticed but devastating relationship?. Med. Hypotheses 1991, 34(2):131-140.
39. J.G. Hattersley, Few medical practitioners know that high doses of vitamin B12 can prevent and even reverse the symptoms of Alzheimer's disease and other mental illnesses, but new Codex regulations will restrict access to such high-dosage vitamin therapy.
40. Douaud G., Refsum H., de Jager C.A., Jacoby R., Nichols T.E., Smith S.M., et al. Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment. Proc. Natl. Acad. Sci. U.S.A. 2013, 110(23):9523-9528.
41. West B. Brain function and antacids. Health Alert 1995, 12(4):3-4.
42. Watanabe F., Abe K., Fujita T., Goto M., Hiemori M., Nakano Y. Effects of microwave heating on the loss of vitamin B(12) in foods. J. Agric. Food Chem. 1998, 46(1):206-210.
43. Varga E.A., Sturm A.C., Misita C.P., Moll S. Homocysteine and MTHFR mutations relation to thrombosis and coronary artery disease. Circulation 2005, 111(19):e289-e293.
44. Refsum H., Nurk E., Smith A.D., Ueland P.M., Gjesdal C.G., Bjelland I., et al. The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J. Nutr. 2006, 136(6):1731S-1740S.
45. Bathum L., Petersen I., Christiansen L., Konieczna A., Sørensen T.I., Kyvik K.O. Genetic and environmental influences on plasma homocysteine: results from a Danish twin study. Clin. Chem. 2007, 53(5):971-979.
46. Jacques P.F., Rosenberg I.H., Rogers G., Selhub J., Bowman B.A., Gunter E.W., et al. Serum total homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey. Am. J. Clin. Nutr. 1999, 69(3):482-489.
47. Nygård O., Vollset S.E., Refsum H., Stensvold I., Tverdal A., Nordrehaug J.E., et al. Total plasma homocysteine and cardiovascular risk profile: the Hordaland Homocysteine Study. JAMA 1995, 274(19):1526-1533.
48. Guttormsen A.B., Ueland P.M., Svarstad E., Refsum H. Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney Int. 1997, 52(2):495-502.
49. Brattström L., Lindgren A., Israelsson B., Andersson A., Hultberg B. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J. Intern. Med. 1994, 236(6):633-641.